img

Global Opioid Receptor Agonist Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Opioid Receptor Agonist Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Opioids are a type of painkiller that works by acting on the neurological system. They're mostly utilized for anaesthetic and pain relief. An agonist is a pharmacological molecule that activates specific brain receptors. When only a small number of receptors are engaged, this agonist elicits a strong physiological/pharmacological response, indicating that the medication has high intrinsic activity. Fentanyl, morphine, dihydromorphinone, meperidine, oxycodone, and oxymorphone are all strong agonist opioids. Opioid receptors are G-protein-coupled inhibitors that are primarily found in peripheral tissues and interfere with opioid receptors' pain-signaling function. Agonists are pain relievers that function by binding opioid receptors and reducing pain experience.
Opioid Receptor Agonist report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Opioid Receptor Agonist market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospital Pharmacy and Online Pharmacy are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Opioid Receptor Agonist industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Opioid Receptor Agonist key manufacturers include Teva Pharmaceutical Industries, Johnson & Johnson, Pfizer, Fresenius Kabi, Mylan N.V., Allergan, US WorldMeds, Piramal Critical Care and DAIICHI SANKYO COMPANY, etc. Teva Pharmaceutical Industries, Johnson & Johnson, Pfizer are top 3 players and held % sales share in total in 2022.
Opioid Receptor Agonist can be divided into Fentanyl, Codeine, Morphine and Others, etc. Fentanyl is the mainstream product in the market, accounting for % sales share globally in 2022.
Opioid Receptor Agonist is widely used in various fields, such as Hospital Pharmacy, Online Pharmacy and Retail Pharmacy,, etc. Hospital Pharmacy provides greatest supports to the Opioid Receptor Agonist industry development. In 2022, global % sales of Opioid Receptor Agonist went into Hospital Pharmacy filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Opioid Receptor Agonist market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Teva Pharmaceutical Industries
Johnson & Johnson
Pfizer
Fresenius Kabi
Mylan N.V.
Allergan
US WorldMeds
Piramal Critical Care
DAIICHI SANKYO COMPANY
Purdue Pharma
Hikma Pharmaceuticals
Endo Pharmaceuticals
Sun Pharmaceutical Industries
Tris Pharma
Indivior
Segment by Type
Fentanyl
Codeine
Morphine
Others

Segment by Application


Hospital Pharmacy
Online Pharmacy
Retail Pharmacy

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Opioid Receptor Agonist market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Opioid Receptor Agonist, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Opioid Receptor Agonist industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Opioid Receptor Agonist in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Opioid Receptor Agonist introduction, etc. Opioid Receptor Agonist Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Opioid Receptor Agonist market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Opioid Receptor Agonist Market Overview
1.1 Opioid Receptor Agonist Product Overview
1.2 Opioid Receptor Agonist Market Segment by Type
1.2.1 Fentanyl
1.2.2 Codeine
1.2.3 Morphine
1.2.4 Others
1.3 Global Opioid Receptor Agonist Market Size by Type
1.3.1 Global Opioid Receptor Agonist Market Size Overview by Type (2024-2034)
1.3.2 Global Opioid Receptor Agonist Historic Market Size Review by Type (2024-2024)
1.3.3 Global Opioid Receptor Agonist Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Opioid Receptor Agonist Sales Breakdown by Type (2024-2024)
1.4.2 Europe Opioid Receptor Agonist Sales Breakdown by Type (2024-2024)
1.4.3 Asia-Pacific Opioid Receptor Agonist Sales Breakdown by Type (2024-2024)
1.4.4 Latin America Opioid Receptor Agonist Sales Breakdown by Type (2024-2024)
1.4.5 Middle East and Africa Opioid Receptor Agonist Sales Breakdown by Type (2024-2024)
2 Global Opioid Receptor Agonist Market Competition by Company
2.1 Global Top Players by Opioid Receptor Agonist Sales (2024-2024)
2.2 Global Top Players by Opioid Receptor Agonist Revenue (2024-2024)
2.3 Global Top Players by Opioid Receptor Agonist Price (2024-2024)
2.4 Global Top Manufacturers Opioid Receptor Agonist Manufacturing Base Distribution, Sales Area, Product Type
2.5 Opioid Receptor Agonist Market Competitive Situation and Trends
2.5.1 Opioid Receptor Agonist Market Concentration Rate (2024-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Opioid Receptor Agonist Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Opioid Receptor Agonist as of 2022)
2.7 Date of Key Manufacturers Enter into Opioid Receptor Agonist Market
2.8 Key Manufacturers Opioid Receptor Agonist Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Opioid Receptor Agonist Status and Outlook by Region
3.1 Global Opioid Receptor Agonist Market Size and CAGR by Region: 2024 VS 2022 VS 2034
3.2 Global Opioid Receptor Agonist Historic Market Size by Region
3.2.1 Global Opioid Receptor Agonist Sales in Volume by Region (2024-2024)
3.2.2 Global Opioid Receptor Agonist Sales in Value by Region (2024-2024)
3.2.3 Global Opioid Receptor Agonist Sales (Volume & Value) Price and Gross Margin (2024-2024)
3.3 Global Opioid Receptor Agonist Forecasted Market Size by Region
3.3.1 Global Opioid Receptor Agonist Sales in Volume by Region (2024-2034)
3.3.2 Global Opioid Receptor Agonist Sales in Value by Region (2024-2034)
3.3.3 Global Opioid Receptor Agonist Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Opioid Receptor Agonist by Application
4.1 Opioid Receptor Agonist Market Segment by Application
4.1.1 Hospital Pharmacy
4.1.2 Online Pharmacy
4.1.3 Retail Pharmacy
4.2 Global Opioid Receptor Agonist Market Size by Application
4.2.1 Global Opioid Receptor Agonist Market Size Overview by Application (2024-2034)
4.2.2 Global Opioid Receptor Agonist Historic Market Size Review by Application (2024-2024)
4.2.3 Global Opioid Receptor Agonist Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Opioid Receptor Agonist Sales Breakdown by Application (2024-2024)
4.3.2 Europe Opioid Receptor Agonist Sales Breakdown by Application (2024-2024)
4.3.3 Asia-Pacific Opioid Receptor Agonist Sales Breakdown by Application (2024-2024)
4.3.4 Latin America Opioid Receptor Agonist Sales Breakdown by Application (2024-2024)
4.3.5 Middle East and Africa Opioid Receptor Agonist Sales Breakdown by Application (2024-2024)
5 North America Opioid Receptor Agonist by Country
5.1 North America Opioid Receptor Agonist Historic Market Size by Country
5.1.1 North America Opioid Receptor Agonist Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
5.1.2 North America Opioid Receptor Agonist Sales in Volume by Country (2024-2024)
5.1.3 North America Opioid Receptor Agonist Sales in Value by Country (2024-2024)
5.2 North America Opioid Receptor Agonist Forecasted Market Size by Country
5.2.1 North America Opioid Receptor Agonist Sales in Volume by Country (2024-2034)
5.2.2 North America Opioid Receptor Agonist Sales in Value by Country (2024-2034)
6 Europe Opioid Receptor Agonist by Country
6.1 Europe Opioid Receptor Agonist Historic Market Size by Country
6.1.1 Europe Opioid Receptor Agonist Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
6.1.2 Europe Opioid Receptor Agonist Sales in Volume by Country (2024-2024)
6.1.3 Europe Opioid Receptor Agonist Sales in Value by Country (2024-2024)
6.2 Europe Opioid Receptor Agonist Forecasted Market Size by Country
6.2.1 Europe Opioid Receptor Agonist Sales in Volume by Country (2024-2034)
6.2.2 Europe Opioid Receptor Agonist Sales in Value by Country (2024-2034)
7 Asia-Pacific Opioid Receptor Agonist by Region
7.1 Asia-Pacific Opioid Receptor Agonist Historic Market Size by Region
7.1.1 Asia-Pacific Opioid Receptor Agonist Market Size Growth Rate (CAGR) by Region: 2024 VS 2022 VS 2034
7.1.2 Asia-Pacific Opioid Receptor Agonist Sales in Volume by Region (2024-2024)
7.1.3 Asia-Pacific Opioid Receptor Agonist Sales in Value by Region (2024-2024)
7.2 Asia-Pacific Opioid Receptor Agonist Forecasted Market Size by Region
7.2.1 Asia-Pacific Opioid Receptor Agonist Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Opioid Receptor Agonist Sales in Value by Region (2024-2034)
8 Latin America Opioid Receptor Agonist by Country
8.1 Latin America Opioid Receptor Agonist Historic Market Size by Country
8.1.1 Latin America Opioid Receptor Agonist Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
8.1.2 Latin America Opioid Receptor Agonist Sales in Volume by Country (2024-2024)
8.1.3 Latin America Opioid Receptor Agonist Sales in Value by Country (2024-2024)
8.2 Latin America Opioid Receptor Agonist Forecasted Market Size by Country
8.2.1 Latin America Opioid Receptor Agonist Sales in Volume by Country (2024-2034)
8.2.2 Latin America Opioid Receptor Agonist Sales in Value by Country (2024-2034)
9 Middle East and Africa Opioid Receptor Agonist by Country
9.1 Middle East and Africa Opioid Receptor Agonist Historic Market Size by Country
9.1.1 Middle East and Africa Opioid Receptor Agonist Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
9.1.2 Middle East and Africa Opioid Receptor Agonist Sales in Volume by Country (2024-2024)
9.1.3 Middle East and Africa Opioid Receptor Agonist Sales in Value by Country (2024-2024)
9.2 Middle East and Africa Opioid Receptor Agonist Forecasted Market Size by Country
9.2.1 Middle East and Africa Opioid Receptor Agonist Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Opioid Receptor Agonist Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Teva Pharmaceutical Industries
10.1.1 Teva Pharmaceutical Industries Company Information
10.1.2 Teva Pharmaceutical Industries Introduction and Business Overview
10.1.3 Teva Pharmaceutical Industries Opioid Receptor Agonist Sales, Revenue and Gross Margin (2024-2024)
10.1.4 Teva Pharmaceutical Industries Opioid Receptor Agonist Products Offered
10.1.5 Teva Pharmaceutical Industries Recent Development
10.2 Johnson & Johnson
10.2.1 Johnson & Johnson Company Information
10.2.2 Johnson & Johnson Introduction and Business Overview
10.2.3 Johnson & Johnson Opioid Receptor Agonist Sales, Revenue and Gross Margin (2024-2024)
10.2.4 Johnson & Johnson Opioid Receptor Agonist Products Offered
10.2.5 Johnson & Johnson Recent Development
10.3 Pfizer
10.3.1 Pfizer Company Information
10.3.2 Pfizer Introduction and Business Overview
10.3.3 Pfizer Opioid Receptor Agonist Sales, Revenue and Gross Margin (2024-2024)
10.3.4 Pfizer Opioid Receptor Agonist Products Offered
10.3.5 Pfizer Recent Development
10.4 Fresenius Kabi
10.4.1 Fresenius Kabi Company Information
10.4.2 Fresenius Kabi Introduction and Business Overview
10.4.3 Fresenius Kabi Opioid Receptor Agonist Sales, Revenue and Gross Margin (2024-2024)
10.4.4 Fresenius Kabi Opioid Receptor Agonist Products Offered
10.4.5 Fresenius Kabi Recent Development
10.5 Mylan N.V.
10.5.1 Mylan N.V. Company Information
10.5.2 Mylan N.V. Introduction and Business Overview
10.5.3 Mylan N.V. Opioid Receptor Agonist Sales, Revenue and Gross Margin (2024-2024)
10.5.4 Mylan N.V. Opioid Receptor Agonist Products Offered
10.5.5 Mylan N.V. Recent Development
10.6 Allergan
10.6.1 Allergan Company Information
10.6.2 Allergan Introduction and Business Overview
10.6.3 Allergan Opioid Receptor Agonist Sales, Revenue and Gross Margin (2024-2024)
10.6.4 Allergan Opioid Receptor Agonist Products Offered
10.6.5 Allergan Recent Development
10.7 US WorldMeds
10.7.1 US WorldMeds Company Information
10.7.2 US WorldMeds Introduction and Business Overview
10.7.3 US WorldMeds Opioid Receptor Agonist Sales, Revenue and Gross Margin (2024-2024)
10.7.4 US WorldMeds Opioid Receptor Agonist Products Offered
10.7.5 US WorldMeds Recent Development
10.8 Piramal Critical Care
10.8.1 Piramal Critical Care Company Information
10.8.2 Piramal Critical Care Introduction and Business Overview
10.8.3 Piramal Critical Care Opioid Receptor Agonist Sales, Revenue and Gross Margin (2024-2024)
10.8.4 Piramal Critical Care Opioid Receptor Agonist Products Offered
10.8.5 Piramal Critical Care Recent Development
10.9 DAIICHI SANKYO COMPANY
10.9.1 DAIICHI SANKYO COMPANY Company Information
10.9.2 DAIICHI SANKYO COMPANY Introduction and Business Overview
10.9.3 DAIICHI SANKYO COMPANY Opioid Receptor Agonist Sales, Revenue and Gross Margin (2024-2024)
10.9.4 DAIICHI SANKYO COMPANY Opioid Receptor Agonist Products Offered
10.9.5 DAIICHI SANKYO COMPANY Recent Development
10.10 Purdue Pharma
10.10.1 Purdue Pharma Company Information
10.10.2 Purdue Pharma Introduction and Business Overview
10.10.3 Purdue Pharma Opioid Receptor Agonist Sales, Revenue and Gross Margin (2024-2024)
10.10.4 Purdue Pharma Opioid Receptor Agonist Products Offered
10.10.5 Purdue Pharma Recent Development
10.11 Hikma Pharmaceuticals
10.11.1 Hikma Pharmaceuticals Company Information
10.11.2 Hikma Pharmaceuticals Introduction and Business Overview
10.11.3 Hikma Pharmaceuticals Opioid Receptor Agonist Sales, Revenue and Gross Margin (2024-2024)
10.11.4 Hikma Pharmaceuticals Opioid Receptor Agonist Products Offered
10.11.5 Hikma Pharmaceuticals Recent Development
10.12 Endo Pharmaceuticals
10.12.1 Endo Pharmaceuticals Company Information
10.12.2 Endo Pharmaceuticals Introduction and Business Overview
10.12.3 Endo Pharmaceuticals Opioid Receptor Agonist Sales, Revenue and Gross Margin (2024-2024)
10.12.4 Endo Pharmaceuticals Opioid Receptor Agonist Products Offered
10.12.5 Endo Pharmaceuticals Recent Development
10.13 Sun Pharmaceutical Industries
10.13.1 Sun Pharmaceutical Industries Company Information
10.13.2 Sun Pharmaceutical Industries Introduction and Business Overview
10.13.3 Sun Pharmaceutical Industries Opioid Receptor Agonist Sales, Revenue and Gross Margin (2024-2024)
10.13.4 Sun Pharmaceutical Industries Opioid Receptor Agonist Products Offered
10.13.5 Sun Pharmaceutical Industries Recent Development
10.14 Tris Pharma
10.14.1 Tris Pharma Company Information
10.14.2 Tris Pharma Introduction and Business Overview
10.14.3 Tris Pharma Opioid Receptor Agonist Sales, Revenue and Gross Margin (2024-2024)
10.14.4 Tris Pharma Opioid Receptor Agonist Products Offered
10.14.5 Tris Pharma Recent Development
10.15 Indivior
10.15.1 Indivior Company Information
10.15.2 Indivior Introduction and Business Overview
10.15.3 Indivior Opioid Receptor Agonist Sales, Revenue and Gross Margin (2024-2024)
10.15.4 Indivior Opioid Receptor Agonist Products Offered
10.15.5 Indivior Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Opioid Receptor Agonist Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Opioid Receptor Agonist Industrial Chain Analysis
11.4 Opioid Receptor Agonist Market Dynamics
11.4.1 Opioid Receptor Agonist Industry Trends
11.4.2 Opioid Receptor Agonist Market Drivers
11.4.3 Opioid Receptor Agonist Market Challenges
11.4.4 Opioid Receptor Agonist Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Opioid Receptor Agonist Distributors
12.3 Opioid Receptor Agonist Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Fentanyl
Table 2. Major Company of Codeine
Table 3. Major Company of Morphine
Table 4. Major Company of Others
Table 5. Global Opioid Receptor Agonist Sales by Type 2024 VS 2022 VS 2034 (US$ Million)
Table 6. Global Opioid Receptor Agonist Sales by Type (2024-2024) & (K Units)
Table 7. Global Opioid Receptor Agonist Sales Market Share in Volume by Type (2024-2024)
Table 8. Global Opioid Receptor Agonist Sales by Type (2024-2024) & (US& Million)
Table 9. Global Opioid Receptor Agonist Market Share in Value by Type (2024-2024)
Table 10. Global Opioid Receptor Agonist Price by Type (2024-2024) & (US$/Unit)
Table 11. Global Opioid Receptor Agonist Sales by Type (2024-2034) & (K Units)
Table 12. Global Opioid Receptor Agonist Sales Market Share in Volume by Type (2024-2034)
Table 13. Global Opioid Receptor Agonist Sales by Type (2024-2034) & (US$ Million)
Table 14. Global Opioid Receptor Agonist Sales Market Share in Value by Type (2024-2034)
Table 15. Global Opioid Receptor Agonist Price by Type (2024-2034) & (US$/Unit)
Table 16. North America Opioid Receptor Agonist Sales by Type (2024-2024) & (K Units)
Table 17. North America Opioid Receptor Agonist Sales by Type (2024-2024) & (US$ Million)
Table 18. Europe Opioid Receptor Agonist Sales (K Units) by Type (2024-2024)
Table 19. Europe Opioid Receptor Agonist Sales by Type (2024-2024) & (US$ Million)
Table 20. Asia-Pacific Opioid Receptor Agonist Sales (K Units) by Type (2024-2024)
Table 21. Asia-Pacific Opioid Receptor Agonist Sales by Type (2024-2024) & (US$ Million)
Table 22. Latin America Opioid Receptor Agonist Sales (K Units) by Type (2024-2024)
Table 23. Latin America Opioid Receptor Agonist Sales by Type (2024-2024) & (US$ Million)
Table 24. Middle East and Africa Opioid Receptor Agonist Sales (K Units) by Type (2024-2024)
Table 25. Middle East and Africa Opioid Receptor Agonist Sales by Type (2024-2024) & (US$ Million)
Table 26. Global Opioid Receptor Agonist Sales by Company (2024-2024) & (K Units)
Table 27. Global Opioid Receptor Agonist Sales Share by Company (2024-2024)
Table 28. Global Opioid Receptor Agonist Revenue by Company (2024-2024) & (US$ Million)
Table 29. Global Opioid Receptor Agonist Revenue Share by Company (2024-2024)
Table 30. Global Market Opioid Receptor Agonist Price by Company (2024-2024) & (US$/Unit)
Table 31. Global Opioid Receptor Agonist Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 32. Global Opioid Receptor Agonist Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Opioid Receptor Agonist as of 2022)
Table 34. Date of Key Manufacturers Enter into Opioid Receptor Agonist Market
Table 35. Key Manufacturers Opioid Receptor Agonist Product Type
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global Opioid Receptor Agonist Market Size Comparison by Region (US$ Million): 2024 VS 2022 VS 2034
Table 38. Global Opioid Receptor Agonist Sales by Region (2024-2024) & (K Units)
Table 39. Global Opioid Receptor Agonist Sales Market Share in Volume by Region (2024-2024)
Table 40. Global Opioid Receptor Agonist Sales by Region (2024-2024) & (US$ Million)
Table 41. Global Opioid Receptor Agonist Sales Market Share in Value by Region (2024-2024)
Table 42. Global Opioid Receptor Agonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 43. Global Opioid Receptor Agonist Sales by Region (2024-2034) & (K Units)
Table 44. Global Opioid Receptor Agonist Sales Market Share in Volume by Region (2024-2034)
Table 45. Global Opioid Receptor Agonist Sales by Region (2024-2034) & (US$ Million)
Table 46. Global Opioid Receptor Agonist Sales Market Share in Value by Region (2024-2034)
Table 47. Global Opioid Receptor Agonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2034)
Table 48. Global Opioid Receptor Agonist Sales by Application: 2024 VS 2022 VS 2034 (US$ Million)
Table 49. Global Opioid Receptor Agonist Sales by Application (2024-2024) & (K Units)
Table 50. Global Opioid Receptor Agonist Sales Market Share in Volume by Application (2024-2024)
Table 51. Global Opioid Receptor Agonist Sales by Application (2024-2024) & (US$ Million)
Table 52. Global Opioid Receptor Agonist Sales Market Share in Value by Application (2024-2024)
Table 53. Global Opioid Receptor Agonist Price by Application (2024-2024) & (US$/Unit)
Table 54. Global Opioid Receptor Agonist Sales by Application (2024-2034) & (K Units)
Table 55. Global Opioid Receptor Agonist Sales Market Share in Volume by Application (2024-2034)
Table 56. Global Opioid Receptor Agonist Sales by Application (2024-2034) & (US$ Million)
Table 57. Global Opioid Receptor Agonist Sales Market Share in Value by Application (2024-2034)
Table 58. Global Opioid Receptor Agonist Price by Application (2024-2034) & (US$/Unit)
Table 59. North America Opioid Receptor Agonist Sales by Application (2024-2024) (K Units)
Table 60. North America Opioid Receptor Agonist Sales by Application (2024-2024) & (US$ Million)
Table 61. Europe Opioid Receptor Agonist Sales by Application (2024-2024) (K Units)
Table 62. Europe Opioid Receptor Agonist Sales by Application (2024-2024) & (US$ Million)
Table 63. Asia-Pacific Opioid Receptor Agonist Sales by Application (2024-2024) (K Units)
Table 64. Asia-Pacific Opioid Receptor Agonist Sales by Application (2024-2024) & (US$ Million)
Table 65. Latin America Opioid Receptor Agonist Sales by Application (2024-2024) (K Units)
Table 66. Latin America Opioid Receptor Agonist Sales by Application (2024-2024) & (US$ Million)
Table 67. Middle East and Africa Opioid Receptor Agonist Sales by Application (2024-2024) (K Units)
Table 68. Middle East and Africa Opioid Receptor Agonist Sales by Application (2024-2024) & (US$ Million)
Table 69. North America Opioid Receptor Agonist Sales by Country (2024-2024) & (K Units)
Table 70. North America Opioid Receptor Agonist Sales Market Share in Volume by Country (2024-2024)
Table 71. North America Opioid Receptor Agonist Sales by Country (2024-2024) & (US$ Million)
Table 72. North America Opioid Receptor Agonist Sales Market Share in Value by Country (2024-2024)
Table 73. North America Opioid Receptor Agonist Sales by Country (2024-2034) & (K Units)
Table 74. North America Opioid Receptor Agonist Sales Market Share in Volume by Country (2024-2034)
Table 75. North America Opioid Receptor Agonist Sales by Country (2024-2034) & (US$ Million)
Table 76. North America Opioid Receptor Agonist Sales Market Share in Value by Country (2024-2034)
Table 77. Europe Opioid Receptor Agonist Sales by Country (2024-2024) & (K Units)
Table 78. Europe Opioid Receptor Agonist Sales Market Share in Volume by Country (2024-2024)
Table 79. Europe Opioid Receptor Agonist Sales by Country (2024-2024) & (US$ Million)
Table 80. Europe Opioid Receptor Agonist Sales Market Share in Value by Country (2024-2024)
Table 81. Europe Opioid Receptor Agonist Sales by Country (2024-2034) & (K Units)
Table 82. Europe Opioid Receptor Agonist Sales Market Share in Volume by Country (2024-2034)
Table 83. Europe Opioid Receptor Agonist Sales by Country (2024-2034) & (US$ Million)
Table 84. Europe Opioid Receptor Agonist Sales Market Share in Value by Country (2024-2034)
Table 85. Asia-Pacific Opioid Receptor Agonist Sales by Region (2024-2024) & (K Units)
Table 86. Asia-Pacific Opioid Receptor Agonist Sales Market Share in Volume by Region (2024-2024)
Table 87. Asia-Pacific Opioid Receptor Agonist Sales by Region (2024-2024) & (US$ Million)
Table 88. Asia-Pacific Opioid Receptor Agonist Sales Market Share in Value by Region (2024-2024)
Table 89. Asia-Pacific Opioid Receptor Agonist Sales by Region (2024-2034) & (K Units)
Table 90. Asia-Pacific Opioid Receptor Agonist Sales Market Share in Volume by Region (2024-2034)
Table 91. Asia-Pacific Opioid Receptor Agonist Sales by Region (2024-2034) & (US$ Million)
Table 92. Asia-Pacific Opioid Receptor Agonist Sales Market Share in Value by Region (2024-2034)
Table 93. Latin America Opioid Receptor Agonist Sales by Country (2024-2024) & (K Units)
Table 94. Latin America Opioid Receptor Agonist Sales Market Share in Volume by Country (2024-2024)
Table 95. Latin America Opioid Receptor Agonist Sales by Country (2024-2024) & (US$ Million)
Table 96. Latin America Opioid Receptor Agonist Sales Market Share in Value by Country (2024-2024)
Table 97. Latin America Opioid Receptor Agonist Sales by Country (2024-2034) & (K Units)
Table 98. Latin America Opioid Receptor Agonist Sales Market Share in Volume by Country (2024-2034)
Table 99. Latin America Opioid Receptor Agonist Sales by Country (2024-2034) & (US$ Million)
Table 100. Latin America Opioid Receptor Agonist Sales Market Share in Value by Country (2024-2034)
Table 101. Middle East and Africa Opioid Receptor Agonist Sales by Country (2024-2024) & (K Units)
Table 102. Middle East and Africa Opioid Receptor Agonist Sales Market Share in Volume by Country (2024-2024)
Table 103. Middle East and Africa Opioid Receptor Agonist Sales by Country (2024-2024) & (US$ Million)
Table 104. Middle East and Africa Opioid Receptor Agonist Sales Market Share in Value by Country (2024-2024)
Table 105. Middle East and Africa Opioid Receptor Agonist Sales by Country (2024-2034) & (K Units)
Table 106. Middle East and Africa Opioid Receptor Agonist Sales Market Share in Volume by Country (2024-2034)
Table 107. Middle East and Africa Opioid Receptor Agonist Sales by Country (2024-2034) & (US$ Million)
Table 108. Middle East and Africa Opioid Receptor Agonist Sales Market Share in Value by Country (2024-2034)
Table 109. Teva Pharmaceutical Industries Company Information
Table 110. Teva Pharmaceutical Industries Introduction and Business Overview
Table 111. Teva Pharmaceutical Industries Opioid Receptor Agonist Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 112. Teva Pharmaceutical Industries Opioid Receptor Agonist Product
Table 113. Teva Pharmaceutical Industries Recent Development
Table 114. Johnson & Johnson Company Information
Table 115. Johnson & Johnson Introduction and Business Overview
Table 116. Johnson & Johnson Opioid Receptor Agonist Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 117. Johnson & Johnson Opioid Receptor Agonist Product
Table 118. Johnson & Johnson Recent Development
Table 119. Pfizer Company Information
Table 120. Pfizer Introduction and Business Overview
Table 121. Pfizer Opioid Receptor Agonist Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 122. Pfizer Opioid Receptor Agonist Product
Table 123. Pfizer Recent Development
Table 124. Fresenius Kabi Company Information
Table 125. Fresenius Kabi Introduction and Business Overview
Table 126. Fresenius Kabi Opioid Receptor Agonist Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 127. Fresenius Kabi Opioid Receptor Agonist Product
Table 128. Fresenius Kabi Recent Development
Table 129. Mylan N.V. Company Information
Table 130. Mylan N.V. Introduction and Business Overview
Table 131. Mylan N.V. Opioid Receptor Agonist Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 132. Mylan N.V. Opioid Receptor Agonist Product
Table 133. Mylan N.V. Recent Development
Table 134. Allergan Company Information
Table 135. Allergan Introduction and Business Overview
Table 136. Allergan Opioid Receptor Agonist Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 137. Allergan Opioid Receptor Agonist Product
Table 138. Allergan Recent Development
Table 139. US WorldMeds Company Information
Table 140. US WorldMeds Introduction and Business Overview
Table 141. US WorldMeds Opioid Receptor Agonist Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 142. US WorldMeds Opioid Receptor Agonist Product
Table 143. US WorldMeds Recent Development
Table 144. Piramal Critical Care Company Information
Table 145. Piramal Critical Care Introduction and Business Overview
Table 146. Piramal Critical Care Opioid Receptor Agonist Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 147. Piramal Critical Care Opioid Receptor Agonist Product
Table 148. Piramal Critical Care Recent Development
Table 149. DAIICHI SANKYO COMPANY Company Information
Table 150. DAIICHI SANKYO COMPANY Introduction and Business Overview
Table 151. DAIICHI SANKYO COMPANY Opioid Receptor Agonist Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 152. DAIICHI SANKYO COMPANY Opioid Receptor Agonist Product
Table 153. DAIICHI SANKYO COMPANY Recent Development
Table 154. Purdue Pharma Company Information
Table 155. Purdue Pharma Introduction and Business Overview
Table 156. Purdue Pharma Opioid Receptor Agonist Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 157. Purdue Pharma Opioid Receptor Agonist Product
Table 158. Purdue Pharma Recent Development
Table 159. Hikma Pharmaceuticals Company Information
Table 160. Hikma Pharmaceuticals Introduction and Business Overview
Table 161. Hikma Pharmaceuticals Opioid Receptor Agonist Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 162. Hikma Pharmaceuticals Opioid Receptor Agonist Product
Table 163. Hikma Pharmaceuticals Recent Development
Table 164. Endo Pharmaceuticals Company Information
Table 165. Endo Pharmaceuticals Introduction and Business Overview
Table 166. Endo Pharmaceuticals Opioid Receptor Agonist Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 167. Endo Pharmaceuticals Opioid Receptor Agonist Product
Table 168. Endo Pharmaceuticals Recent Development
Table 169. Sun Pharmaceutical Industries Company Information
Table 170. Sun Pharmaceutical Industries Introduction and Business Overview
Table 171. Sun Pharmaceutical Industries Opioid Receptor Agonist Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 172. Sun Pharmaceutical Industries Opioid Receptor Agonist Product
Table 173. Sun Pharmaceutical Industries Recent Development
Table 174. Tris Pharma Company Information
Table 175. Tris Pharma Introduction and Business Overview
Table 176. Tris Pharma Opioid Receptor Agonist Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 177. Tris Pharma Opioid Receptor Agonist Product
Table 178. Tris Pharma Recent Development
Table 179. Indivior Company Information
Table 180. Indivior Introduction and Business Overview
Table 181. Indivior Opioid Receptor Agonist Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 182. Indivior Opioid Receptor Agonist Product
Table 183. Indivior Recent Development
Table 184. Key Raw Materials Lists
Table 185. Raw Materials Key Suppliers Lists
Table 186. Opioid Receptor Agonist Market Trends
Table 187. Opioid Receptor Agonist Market Drivers
Table 188. Opioid Receptor Agonist Market Challenges
Table 189. Opioid Receptor Agonist Market Restraints
Table 190. Opioid Receptor Agonist Distributors List
Table 191. Opioid Receptor Agonist Downstream Customers
Table 192. Research Programs/Design for This Report
Table 193. Key Data Information from Secondary Sources
Table 194. Key Data Information from Primary Sources
List of Figures
Figure 1. Opioid Receptor Agonist Product Picture
Figure 2. Global Opioid Receptor Agonist Market Size, 2024 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Opioid Receptor Agonist Market Size Status and Outlook (2024-2034) & (US$ Million)
Figure 4. Global Opioid Receptor Agonist Sales Status and Outlook (2024-2034) & (K Units)
Figure 5. Product Picture of Fentanyl
Figure 6. Global Fentanyl Sales YoY Growth (2024-2034) & (K Units)
Figure 7. Product Picture of Codeine
Figure 8. Global Codeine Sales YoY Growth (2024-2034) & (K Units)
Figure 9. Product Picture of Morphine
Figure 10. Global Morphine Sales YoY Growth (2024-2034) & (K Units)
Figure 11. Product Picture of Others
Figure 12. Global Others Sales YoY Growth (2024-2034) & (K Units)
Figure 13. Global Opioid Receptor Agonist Sales by Type (2024-2034) & (US$ Million)
Figure 14. Global Opioid Receptor Agonist Sales Market Share by Type in 2022 & 2034
Figure 15. North America Opioid Receptor Agonist Sales Market Share in Volume by Type in 2022
Figure 16. North America Opioid Receptor Agonist Sales Market Share in Value by Type in 2022
Figure 17. Europe Opioid Receptor Agonist Sales Market Share in Volume by Type in 2022
Figure 18. Europe Opioid Receptor Agonist Sales Market Share in Value by Type in 2022
Figure 19. Asia-Pacific Opioid Receptor Agonist Sales Market Share in Volume by Type in 2022
Figure 20. Asia-Pacific Opioid Receptor Agonist Sales Market Share in Value by Type in 2022
Figure 21. Latin America Opioid Receptor Agonist Sales Market Share in Volume by Type in 2022
Figure 22. Latin America Opioid Receptor Agonist Sales Market Share in Value by Type in 2022
Figure 23. Middle East and Africa Opioid Receptor Agonist Sales Market Share in Volume by Type in 2022
Figure 24. Middle East and Africa Opioid Receptor Agonist Sales Market Share in Value by Type in 2022
Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Opioid Receptor Agonist Sales in 2022
Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by Opioid Receptor Agonist Revenue in 2022
Figure 27. Opioid Receptor Agonist Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2024 VS 2022
Figure 28. Product Picture of Hospital Pharmacy
Figure 29. Global Hospital Pharmacy Sales YoY Growth (2024-2034) & (K Units)
Figure 30. Product Picture of Online Pharmacy
Figure 31. Global Online Pharmacy Sales YoY Growth (2024-2034) & (K Units)
Figure 32. Product Picture of Retail Pharmacy
Figure 33. Global Retail Pharmacy Sales YoY Growth (2024-2034) & (K Units)
Figure 34. Global Opioid Receptor Agonist Sales by Application (2024-2034) & (US$ Million)
Figure 35. Global Opioid Receptor Agonist Sales Market Share by Application in 2022 & 2034
Figure 36. North America Opioid Receptor Agonist Sales Market Share in Volume by Application in 2022
Figure 37. North America Opioid Receptor Agonist Sales Market Share in Value by Application in 2022
Figure 38. Europe Opioid Receptor Agonist Sales Market Share in Volume by Application in 2022
Figure 39. Europe Opioid Receptor Agonist Sales Market Share in Value by Application in 2022
Figure 40. Asia-Pacific Opioid Receptor Agonist Sales Market Share in Volume by Application in 2022
Figure 41. Asia-Pacific Opioid Receptor Agonist Sales Market Share in Value by Application in 2022
Figure 42. Latin America Opioid Receptor Agonist Sales Market Share in Volume by Application in 2022
Figure 43. Latin America Opioid Receptor Agonist Sales Market Share in Value by Application in 2022
Figure 44. Middle East and Africa Opioid Receptor Agonist Sales Market Share in Value by Application in 2022
Figure 45. Key Raw Materials Price
Figure 46. Opioid Receptor Agonist Manufacturing Cost Structure
Figure 47. Opioid Receptor Agonist Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries